News
Swiss biotech company Roche has announced a collaboration with US pharmaceutical company Eli Lilly to develop Roche’s Elecsys Amyloid Plasma Panel (...
Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment of adult patients with...
A new drug to treat ovarian cancer is set to enter the phase 3 UP-NEXT trial imminently. Upifitamab rilsodotin is an antibody-drug conjugate (...
Faron Pharmaceuticals, a clinical stage biopharmaceutical company, has revealed positive FDA feedback and recommendations for its monotherapy for...
BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple...
US-based Gilead Sciences and Nurix have announced that Gilead has exercised its option to exclusively license Nurix’s investigational targeted...
It appears that the FDA is inclined to support Biogen’s amyotrophic lateral sclerosis (ALS) drug, tofersen, with documents released on Monday...